Roles of neck dissection in multidisciplinary treatment -therapeutic efficacy of organ-preserving and less-extensive dissection-

Kenichi Kamizono, Masayoshi Ezima, masahiko taura, Takashi Hara, Muneyuki Masuda

Research output: Contribution to journalArticle

Abstract

In our institute, neck dissection (ND) is considered to be a part of multidisciplinary treatments involving surgery and concurrent chemoradiotherapy (TAR therapy). We have applied modified neck dissection as well as less extensive selective neck dissection to patients with head and neck squamous cell carcinoma, based on a definite policy. During 2004-2008, 45 NDs were performed in 41 patients (33 males and 8 females) at Kyushu Kosei Nenkin Hospital. We retrospectively analyzed the treatment results to validate the therapeutic efficacy of our organ-preserving and less-extensive surgical policy. Classical radical neck dissection was performed in only 4 cases. In 36 (80%) cases, at least two of the spinal accessory nerve, the sternocleidomastoid muscle and the internal jugular were spared, while in 19 (42.2%) cases all three organs were preserved. SND was administered for 31 cases omitting 40% and 48% of the respective level I and V in laryngeal and pharyngeal cancer; 31.6%, 57.9% and 73.7% of the respective level III, IV and V in oral cancer. Among these 31 cases, 24 (66.7%) NDs were carried out as a therapeutic selective neck dissection (TSND) for N+ neck. Lymph node recurrence was observed in only 4 cases (8.9%). The cumulative regional control rate with SND and comprehensive ND were 93.6% and 83.6%, respectively. For N+ cases, 91.7% of the regional control rate was obtained in TSND, while 82.5% was obtained in comprehensive ND. These favorable results indicate that in the multimodality treatment setting, organ-preserving and less-extensive ND are appropriate treatment choices with respect to both QOL and oncological results.

Original languageEnglish
Pages (from-to)97-103
Number of pages7
JournalJapanese Journal of Head and Neck Cancer
Volume37
Issue number1
DOIs
Publication statusPublished - Dec 1 2011

Fingerprint

Neck Dissection
Dissection
Therapeutics
Neck
Pharyngeal Neoplasms
Accessory Nerve
Laryngeal Neoplasms
Mouth Neoplasms
Chemoradiotherapy
Lymph Nodes
Recurrence
Muscles

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology
  • Oncology

Cite this

Roles of neck dissection in multidisciplinary treatment -therapeutic efficacy of organ-preserving and less-extensive dissection-. / Kamizono, Kenichi; Ezima, Masayoshi; taura, masahiko; Hara, Takashi; Masuda, Muneyuki.

In: Japanese Journal of Head and Neck Cancer, Vol. 37, No. 1, 01.12.2011, p. 97-103.

Research output: Contribution to journalArticle

@article{53ae58713eab41278d9f4f5b41465edf,
title = "Roles of neck dissection in multidisciplinary treatment -therapeutic efficacy of organ-preserving and less-extensive dissection-",
abstract = "In our institute, neck dissection (ND) is considered to be a part of multidisciplinary treatments involving surgery and concurrent chemoradiotherapy (TAR therapy). We have applied modified neck dissection as well as less extensive selective neck dissection to patients with head and neck squamous cell carcinoma, based on a definite policy. During 2004-2008, 45 NDs were performed in 41 patients (33 males and 8 females) at Kyushu Kosei Nenkin Hospital. We retrospectively analyzed the treatment results to validate the therapeutic efficacy of our organ-preserving and less-extensive surgical policy. Classical radical neck dissection was performed in only 4 cases. In 36 (80{\%}) cases, at least two of the spinal accessory nerve, the sternocleidomastoid muscle and the internal jugular were spared, while in 19 (42.2{\%}) cases all three organs were preserved. SND was administered for 31 cases omitting 40{\%} and 48{\%} of the respective level I and V in laryngeal and pharyngeal cancer; 31.6{\%}, 57.9{\%} and 73.7{\%} of the respective level III, IV and V in oral cancer. Among these 31 cases, 24 (66.7{\%}) NDs were carried out as a therapeutic selective neck dissection (TSND) for N+ neck. Lymph node recurrence was observed in only 4 cases (8.9{\%}). The cumulative regional control rate with SND and comprehensive ND were 93.6{\%} and 83.6{\%}, respectively. For N+ cases, 91.7{\%} of the regional control rate was obtained in TSND, while 82.5{\%} was obtained in comprehensive ND. These favorable results indicate that in the multimodality treatment setting, organ-preserving and less-extensive ND are appropriate treatment choices with respect to both QOL and oncological results.",
author = "Kenichi Kamizono and Masayoshi Ezima and masahiko taura and Takashi Hara and Muneyuki Masuda",
year = "2011",
month = "12",
day = "1",
doi = "10.5981/jjhnc.37.97",
language = "English",
volume = "37",
pages = "97--103",
journal = "Japanese Journal of Head and Neck Cancer",
issn = "1349-5747",
publisher = "Nihon Tokeibu Gan Gakkai",
number = "1",

}

TY - JOUR

T1 - Roles of neck dissection in multidisciplinary treatment -therapeutic efficacy of organ-preserving and less-extensive dissection-

AU - Kamizono, Kenichi

AU - Ezima, Masayoshi

AU - taura, masahiko

AU - Hara, Takashi

AU - Masuda, Muneyuki

PY - 2011/12/1

Y1 - 2011/12/1

N2 - In our institute, neck dissection (ND) is considered to be a part of multidisciplinary treatments involving surgery and concurrent chemoradiotherapy (TAR therapy). We have applied modified neck dissection as well as less extensive selective neck dissection to patients with head and neck squamous cell carcinoma, based on a definite policy. During 2004-2008, 45 NDs were performed in 41 patients (33 males and 8 females) at Kyushu Kosei Nenkin Hospital. We retrospectively analyzed the treatment results to validate the therapeutic efficacy of our organ-preserving and less-extensive surgical policy. Classical radical neck dissection was performed in only 4 cases. In 36 (80%) cases, at least two of the spinal accessory nerve, the sternocleidomastoid muscle and the internal jugular were spared, while in 19 (42.2%) cases all three organs were preserved. SND was administered for 31 cases omitting 40% and 48% of the respective level I and V in laryngeal and pharyngeal cancer; 31.6%, 57.9% and 73.7% of the respective level III, IV and V in oral cancer. Among these 31 cases, 24 (66.7%) NDs were carried out as a therapeutic selective neck dissection (TSND) for N+ neck. Lymph node recurrence was observed in only 4 cases (8.9%). The cumulative regional control rate with SND and comprehensive ND were 93.6% and 83.6%, respectively. For N+ cases, 91.7% of the regional control rate was obtained in TSND, while 82.5% was obtained in comprehensive ND. These favorable results indicate that in the multimodality treatment setting, organ-preserving and less-extensive ND are appropriate treatment choices with respect to both QOL and oncological results.

AB - In our institute, neck dissection (ND) is considered to be a part of multidisciplinary treatments involving surgery and concurrent chemoradiotherapy (TAR therapy). We have applied modified neck dissection as well as less extensive selective neck dissection to patients with head and neck squamous cell carcinoma, based on a definite policy. During 2004-2008, 45 NDs were performed in 41 patients (33 males and 8 females) at Kyushu Kosei Nenkin Hospital. We retrospectively analyzed the treatment results to validate the therapeutic efficacy of our organ-preserving and less-extensive surgical policy. Classical radical neck dissection was performed in only 4 cases. In 36 (80%) cases, at least two of the spinal accessory nerve, the sternocleidomastoid muscle and the internal jugular were spared, while in 19 (42.2%) cases all three organs were preserved. SND was administered for 31 cases omitting 40% and 48% of the respective level I and V in laryngeal and pharyngeal cancer; 31.6%, 57.9% and 73.7% of the respective level III, IV and V in oral cancer. Among these 31 cases, 24 (66.7%) NDs were carried out as a therapeutic selective neck dissection (TSND) for N+ neck. Lymph node recurrence was observed in only 4 cases (8.9%). The cumulative regional control rate with SND and comprehensive ND were 93.6% and 83.6%, respectively. For N+ cases, 91.7% of the regional control rate was obtained in TSND, while 82.5% was obtained in comprehensive ND. These favorable results indicate that in the multimodality treatment setting, organ-preserving and less-extensive ND are appropriate treatment choices with respect to both QOL and oncological results.

UR - http://www.scopus.com/inward/record.url?scp=84870260996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870260996&partnerID=8YFLogxK

U2 - 10.5981/jjhnc.37.97

DO - 10.5981/jjhnc.37.97

M3 - Article

AN - SCOPUS:84870260996

VL - 37

SP - 97

EP - 103

JO - Japanese Journal of Head and Neck Cancer

JF - Japanese Journal of Head and Neck Cancer

SN - 1349-5747

IS - 1

ER -